| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.283 | 30.612 | 4.520 | 4.228 | 2.941 | 10.727 | 10.174 | 1.400 | 3.682 | 1.086 |
| Total Income - EUR | 22.292 | 30.808 | 4.569 | 4.248 | 2.947 | 10.736 | 10.198 | 1.404 | 3.682 | 1.086 |
| Total Expenses - EUR | 19.867 | 38.924 | 6.491 | 980 | 1.566 | 7.795 | 3.127 | 3.005 | 2.280 | 848 |
| Gross Profit/Loss - EUR | 2.426 | -8.116 | -1.922 | 3.268 | 1.381 | 2.941 | 7.071 | -1.601 | 1.402 | 239 |
| Net Profit/Loss - EUR | 1.757 | -8.662 | -2.025 | 3.141 | 1.293 | 2.618 | 6.765 | -1.643 | 1.165 | 200 |
| Employees | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biosan S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.544 | 1.423 | 682 | 1.564 | 1.390 | 229 | 127 | 76 | 76 | 76 |
| Current Assets | 7.486 | 3.504 | 2.703 | 2.729 | 3.980 | 5.103 | 13.037 | 5.189 | 6.925 | 6.585 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 136 |
| Receivables | 0 | 468 | 387 | 379 | 400 | 246 | 2.464 | 1.621 | 1.447 | 1.294 |
| Cash | 7.486 | 3.036 | 2.316 | 2.350 | 3.581 | 4.858 | 10.573 | 3.568 | 5.478 | 5.155 |
| Shareholders Funds | 9.076 | 321 | -1.709 | 1.462 | 2.727 | 5.293 | 6.887 | 5.265 | 6.415 | 6.579 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 954 | 4.606 | 5.094 | 2.831 | 2.644 | 39 | 6.276 | 0 | 586 | 82 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
9609
|
|||||||||
Comments - Biosan S.r.l.